Cited by 21Probiotics and Fermented FoodsGut microbiota and healthDementia and Cognitive Impairment Research

The Beneficial Effects of Lactobacillus Strains on Gut Microbiome in Alzheimer’s Disease: A Systematic Review

Open access
Quansah, Michael, David, Monique Antoinette, Martins, Ralph, El-Omar, Emad, Aliberti, Silvana Mirella, Capunzo, Mario, Jensen, Slade O., Tayebi, Mourad·2025·Healthcare

Abstract

Background/Objectives: Growing evidence suggests that the gut–brain axis influences brain function, particularly the role of intestinal microbiota in modulating cognitive processes. Probiotics may alter brain function and behavior by modulating gut microbiota, with implications for neurodegenerative diseases like Alzheimer’s disease (AD). The purpose of this review is to systematically review the current literature exploring the effects of probiotic supplementation on gut microbiota and cognitive function in AD and mild cognitive impairment (MCI). Methods: A comprehensive literature search was conducted across PubMed/Medline, Embase, and Scopus to identify relevant randomized controlled trials (RCTs) from inception to 20 August 2024. The search focused on comparing outcomes between intervention and control/placebo groups. Data searches, article selection, data extraction, and risk of bias assessment were performed in accordance with Cochrane guidelines. Systematic Review Registration: PROSPERO registration no: CRD42023446796. Results: Data from four RCTs involving 293 Individuals (AD and MCI patients) receiving mainly Lactobacillus and Bifidobacterium strains showed some beneficial effects on cognitive function, altered gut microbiota composition, and positively affected metabolic biomarkers. However, variability in microbiota assessment across studies limits the interpretation of results. The limited number and quality of the existing studies make it difficult to draw definitive conclusions from the data. Additional high-quality research is clearly needed. Conclusions: Probiotics show promise as an adjunctive intervention for cognitive decline, but larger, long-term trials are needed to confirm their efficacy and clinical applicability in neurodegenerative diseases like AD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/healthcare13010074

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The human microbiome plays a fundamental role in health maintenance and the aging process.

    “The human microbiome, a vast ecosystem of microorganisms residing in the gut, skin, respiratory tract, and mucosal surfaces, plays a fundamental role in health maintenance and the aging process [96].”

    From The Power of Environment: A Comprehensive Review of the Exposome's Role in Healthy Aging, Longevity, and Preventive Medicine-Lessons from Blue Zones and Cilento (2025) · cites this paper as [96]

    Section 1.1 (Gut Microbiome; page unavailable) says the human microbiome plays essential roles in regulating health and disease and describes microorganisms at several body sites. It says age can shape gut microbiome composition, but does not say the microbiome plays a fundamental role in the aging process. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 59 · Cited by 21

Research works printed but not linked: 53

  1. [1]Walters M.J. Sterling J. Quinn C. Ganzer C. Osorio R.S. Andrews R.D. Matthews D.C. Vallabhajosula S. de Leon M. Isaacson R.S. Associations of lifestyle and vascular risk factors with Alzheimer’s brain biomarker changes during middleage: A 3-year longitudinal study in the broader New York City area BMJ Open 2018 8 e023664 10.1136/bmjopen-2018-023664 30478117 PMC6254410 · DOI
  2. [3]Mosconi L. Walters M. Sterling J. Quinn C. McHugh P. E Andrews R. Matthews D.C. Ganzer C. Osorio R.S. Isaacson R.S. Lifestyle and vascular risk effects on MRI-based biomarkers of Alzheimer’s disease: A cross-sectional study of middle-aged adults from the broader New York City area BMJ Open 2018 8 e019362 10.1136/bmjopen-2017-019362 PMC5875649 29574441 · DOI
  3. [5]Killin L.O.J. Starr J.M. Shiue I.J. Russ T.C. Environmental risk factors for dementia: A systematic review BMC Geriatr. 2016 16 175 10.1186/s12877-016-0342-y 27729011 PMC5059894 · DOI
  4. [6]Aliberti S.M. Donato A. Funk R.H.W. Capunzo M. A Narrative Review Exploring the Similarities between Cilento and the Already Defined “Blue Zones” in Terms of Environment, Nutrition, and Lifestyle: Can Cilento Be Considered an Undefined “Blue Zone”? Nutrients 2024 16 729 10.3390/nu16050729 38474857 PMC10934765 · DOI · Paper page
  5. [8]Aliberti S.M. De Caro F. Funk R.H.W. Schiavo L. Gonnella J. Boccia G. Capunzo M. Extreme Longevity: Analysis of the Direct or Indirect Influence of Environmental Factors on Old, Nonagenarians, and Centenarians in Cilento, Italy Int. J. Environ. Res. Public Health 2022 19 1589 10.3390/ijerph19031589 35162611 PMC8834812 · DOI · Paper page
  6. [10]Hardy J. Bogdanovic N. Winblad B. Portelius E. Andreasen N. Cedazo-Minguez A. Zetterberg H. Pathways to Alzheimer’s disease J. Intern. Med. 2014 275 296 303 10.1111/joim.12192 24749173 · DOI
  7. [11]Lopez O.L. Becker J.T. Chang Y.F. Klunk W.E. Mathis C. Price J. Kuller L.H. Amyloid deposition and brain structure as long-term predictors of MCI, dementia, and mortality Neurology 2018 90 E1920 E1928 10.1212/WNL.0000000000005549 29695596 PMC5962915 · DOI
  8. [12]Lowe V.J. Wiste H.J. Senjem M.L. Weigand S.D. Therneau T.M. Boeve B.F. Jack C.R. Widespread brain tau and its association with ageing, Braak stage and Alzheimer’s dementia Brain 2018 141 271 287 10.1093/brain/awx320 29228201 PMC5837250 · DOI
  9. [13]Ngandu T. Lehtisalo J. Solomon A. Levälahti E. Ahtiluoto S. Antikainen R. Bäckman L. Hänninen T. Jula A. Laatikainen T. A 2 Year Multidomain Intervention of Diet, Exercise, Cognitive Training, and Vascular Risk Monitoring Versus Control to Prevent Cognitive Decline in At-Risk Elderly People (FINGER): A randomised controlled trial Lancet 2015 385 2255 2263 10.1016/S0140-6736(15)60461-5 25771249 · DOI · Paper page
  10. [14]Zhu G. Zhao J. Zhang H. Chen W. Wang G. Probiotics for Mild Cognitive Impairment and Alzheimer’s Disease: A Systematic Review and Meta-Analysis Foods 2021 10 1672 10.3390/foods10071672 34359543 PMC8303183 · DOI
  11. [15]Zheng Y. Bonfili L. Wei T. Eleuteri A.M. Understanding the gut-brain axis and its therapeutic implications for neurodegenerative disorders Nutrients 2023 15 4631 10.3390/nu15214631 37960284 PMC10648099 · DOI · Paper page
  12. [16]Carabotti M. Scirocco A. Maselli M.A. Severi C. The gut-brain axis: Interactions between enteric microbiota, central and enteric nervous systems Ann. Gastroenterol. Q. Publ. Hell. Soc. Gastroenterol. 2015 28 203 PMC4367209 25830558
  13. [17]Jiang C. Li G. Huang P. Liu Z. Zhao B. The gut microbiota and Alzheimer’s disease J. Alzheimer’s Dis. 2017 58 1 15 10.3233/JAD-161141 28372330 · DOI · Paper page
  14. [18]Collins S.M. Bercik P. Intestinal bacteria influence brain activity in healthy humans Nat. Rev. Gastroenterol. Hepatol. 2013 10 326 327 10.1038/nrgastro.2013.76 23648940 · DOI
  15. [19]Gill S.R. Pop M. Deboy R.T. Eckburg P.B. Turnbaugh P.J. Samuel B.S. Gordon J.I. Relman D.A. Fraser-Liggett C.M. Nelson K.E. Metagenomic analysis of the human distal gut microbiome Science 2006 312 1355 1359 10.1126/science.1124234 16741115 PMC3027896 · DOI · Paper page
  16. [20]Qin J. Li R. Raes J. Arumugam M. Burgdorf K.S. Manichanh C. Nielsen T. Pons N. Levenez F. Yamada T. A human gut microbial gene catalogue established by metagenomic sequencing Nature 2010 464 59 65 10.1038/nature08821 20203603 PMC3779803 · DOI · Paper page
  17. [21]O’Hara A.M. Shanahan F. The gut flora as a forgotten organ EMBO Rep. 2006 7 688 693 10.1038/sj.embor.7400731 16819463 PMC1500832 · DOI · Paper page
  18. [22]Turnbaugh P.J. Ley R.E. Hamady M. Fraser-Liggett C.M. Knight R. Gordon J.I. The human microbiome project Nature 2007 449 804 810 10.1038/nature06244 17943116 PMC3709439 · DOI · Paper page
  19. [23]Eckburg P.B. Bik E.M. Bernstein C.N. Purdom E. Dethlefsen L. Sargent M. Gill S.R. Nelson K.E. Relman D.A. Diversity of the Human Intestinal Microbial Flora Science 2005 308 1635 1638 10.1126/science.1110591 15831718 PMC1395357 · DOI · Paper page
  20. [25]Dominguez-Bello M.G. Costello E.K. Contreras M. Magris M. Hidalgo G. Fierer N. Knight R. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns Proc. Natl. Acad. Sci. USA 2010 107 11971 11975 10.1073/pnas.1002601107 20566857 PMC2900693 · DOI · Paper page
  21. [26]Stewart C.J. Ajami N.J. O’Brien J.L. Hutchinson D.S. Smith D.P. Wong M.C. Ross M.C. Lloyd R.E. Doddapaneni H. Metcalf G.A. Temporal development of the gut microbiome in early childhood from the TEDDY study Nature 2018 562 583 588 10.1038/s41586-018-0617-x 30356187 PMC6415775 · DOI
  22. [28]Bercik P. Denou E. Collins J. Jackson W. Lu J. Jury J. Deng Y. Blennerhassett P. Macri J. McCoy K.D. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice Gastroenterology 2011 141 599 609 10.1053/j.gastro.2011.04.052 21683077 · DOI · Paper page
  23. [29]Rogers G.B. Keating D.J. Young R.L. Wong M.L. Licinio J. Wesselingh S. From gut dysbiosis to altered brain function and mental illness: Mechanisms and pathways Mol. Psychiatry 2016 21 738 748 10.1038/mp.2016.50 27090305 PMC4879184 · DOI · Paper page
  24. [30]Sun Y. Baptista L.C. Roberts L.M. Jumbo-Lucioni P. McMahon L.L. Buford T.W. Carter C.S. The gut microbiome as a therapeutic target for cognitive impairment J. Gerontol. A Biol. Sci. Med. Sci. 2020 75 1242 1250 10.1093/gerona/glz281 31811292 PMC7302188 · DOI
  25. [32]Levenstein S. The Very Model of a Modern Etiology: A Biopsychosocial View of Peptic Ulcer Psychosom. Med. 2000 62 176 185 10.1097/00006842-200003000-00003 10772394 · DOI
  26. [33]Spiro H. Peptic Ulcer Is Not a Disease, Only a Sign! Stress Is a Factor in More Than a Few Dyspeptics Psychosom. Med. 2000 62 186 187 10.1097/00006842-200003000-00004 10772395 · DOI
  27. [34]Moger-Reischer R. Lennon J. The Human Superorganism: How the Microbiome IsRevolutionizing the Pursuit of a Healthy Life Q. Rev. Biol. 2017 92 203 10.1086/692223 · DOI
  28. [37]Schroeder B.O. Bäckhed F. Signals from the gut microbiota to distant organs in physiology and disease Nat. Med. 2016 22 1079 1089 10.1038/nm.4185 27711063 · DOI · Paper page
  29. [38]Sherwin E. Sandhu K.V. Dinan T.G. Cryan J.F. May the force be with you: The light and dark sides of the microbiota–gut–brain axis in neuropsychiatry CNS Drugs 2016 30 1019 1041 10.1007/s40263-016-0370-3 27417321 PMC5078156 · DOI
  30. [39]De Vadder F. Kovatcheva-Datchary P. Goncalves D. Vinera J. Zitoun C. Duchampt A. Bäckhed F. Mithieux G. Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits Cell 2014 156 84 96 24412651
  31. [40]Mapstone M. Cheema A.K. Fiandaca M.S. Zhong X. Mhyre T.R. MacArthur L.H. Hall W.J. Fisher S.G. Peterson D.R. Haley J.M. Plasma phospholipids identify antecedent memory impairment in older adults Nat. Med. 2014 20 415 418 24608097 PMC5360460
  32. [42]Gul S. Durante-Mangoni E. Unraveling the Puzzle: Health Benefits of Probiotics—A Comprehensive Review J. Clin. Med. 2024 13 1436 10.3390/jcm13051436 38592298 PMC10935031 · DOI
  33. [45]Farah Z. de Wet N.J. Fermentation and Probiotics for Health and Nutrition Wiley Blackwell Hoboken, NJ, USA 2017
  34. [47]Park K.Y. Kim B. Hyun C.K. Lactobacillus rhamnosus GG improves glucose tolerance through alleviating ER stress and suppressing macrophage activation in db/db mice J. Clin. Biochem. Nutr. 2015 56 240 246 10.3164/jcbn.14-116 26060355 PMC4454087 · DOI
  35. [48]Ganguli K. Collado M.C. Rautava J. Lu L. Satokari R. von Ossowski I. Reunanen J. de Vos W.M. Palva A. Isolauri E. Lactobacillus rhamnosus GG and its SpaC pilus adhesin modulate inflammatory responsiveness and TLR-related gene expression in the fetal human gut Pediatr. Res. 2015 77 528 535.47 10.1038/pr.2015.5 25580735 PMC4465787 · DOI
  36. [49]Bermudez-Brito M. Munoz-Quezada S. Gomez-Llorente C. Romero F. Gil A. Lactobacillus rhamnosus and its cell-free culture supernatant differentially modulate inflammatory biomarkers in Escherichia coli-challenged human dendritic cells Br. J. Nutr. 2014 111 1727 1737 10.1017/S0007114513004303 24480321 · DOI
  37. [50]Kantak P.A. Bobrow D.N. Nyby J.G. Obsessive–compulsive-like behaviors in house mice are attenuated by a probiotic (Lactobacillus rhamnosus GG) Behav. Pharmacol. 2014 25 71 79 10.1097/FBP.0000000000000013 24257436 · DOI
  38. [51]Huang H.J. Chen J.L. Liao J.F. Chen Y.H. Chieu M.W. Ke Y.Y. Hsu C.C. Tsai Y.C. Hsieh-Li H.M. Lactobacillus plantarum PS128 prevents cognitive dysfunction in Alzheimer’s disease mice by modulating propionic acid levels, glycogen synthase kinase 3 beta activity, and gliosis BMC Complement. Med. Ther. 2021 21 259 34627204 PMC8502419
  39. [52]Yun S.W. Park H.S. Shin Y.J. Ma X. Han M.J. Kim D.H. Lactobacillus gasseri NK109 and Its Supplement Alleviate Cognitive Impairment in Mice by Modulating NF-kappaB Activation, BDNF Expression, and Gut Microbiota Composition Nutrients 2023 15 790 36771498 PMC9921112
  40. [53]Lebeer S. Bron P.A. Marco M.L. Van Pijkeren J.P. O’Connell Motherway M. Hill C. Pot B. Roos S. Klaenhammer T. Identification of probiotic effector molecules: Present state and future perspectives Curr. Opin. Biotechnol. 2018 49 217 223 10.1016/j.copbio.2017.10.007 29153882 · DOI
  41. [54]Wang H. Lee I.S. Braun C. Enck P. Effect of probiotics on central nervous system functions in animals and humans: A systematic review J. Neurogastroenterol. Motil. 2016 22 589 10.5056/jnm16018 27413138 PMC5056568 · DOI · Paper page
  42. [56]Agahi A. Hamidi G.A. Daneshvar R. Hamdieh M. Soheili M. Alinaghipour A. Esmaeili Taba S.M. Salami M. Does Severity of Alzheimer’s Disease Contribute to Its Responsiveness to Modifying Gut Microbiota? A Double Blind Clinical Trial Front. Neurol. 2018 9 662 10.3389/fneur.2018.00662 30158897 PMC6104449 · DOI
  43. [57]Akhgarjand C. Vahabi Z. Shab-Bidar S. Etesam F. Djafarian K. Effects of probiotic supplements on cognition, anxiety, and physical activity in subjects with mild and moderate Alzheimer’s disease: A randomized, double-blind, and placebo-controlled study Front. Aging Neurosci. 2022 14 1032494 10.3389/fnagi.2022.1032494 36389063 PMC9647197 · DOI
  44. [58]Asaoka D. Xiao J. Takeda T. Yanagisawa N. Yamazaki T. Matsubara Y. Sato N. Effect of probiotic Bifidobacterium breve in improving cognitive function and preventing brain atrophy in older patients with suspected mild cognitive impairment: Results of a 24-week randomized, double-blind, placebo-controlled trial J. Alzheimer’s Dis. 2022 88 75 95 10.3233/JAD-220148 35570493 PMC9277669 · DOI
  45. [59]Fei Y. Wang R. Lu J. Peng S. Yang S. Wang Y. Li M. Probiotic intervention benefits multiple neural behaviors in older adults with mild cognitive impairment Geriatr. Nurs. 2023 51 167 175 10.1016/j.gerinurse.2023.03.006 36990042 · DOI
  46. [60]De Vries M.C. Vaughan E.E. Kleerebezem M. de Vos W.M. Lactobacillus plantarum—Survival, functional and potential probiotic properties in the human intestinal tract Int. Dairy J. 2006 16 1018 1028 10.1016/j.idairyj.2005.09.003 · DOI
  47. [61]Jeong J.J. Woo J.Y. Kim K.A. Han M.J. Kim D.H. Lactobacillus pentosus var. Plantarum C29 ameliorates age-dependent memory impairment in F ischer 344 rats Lett. Appl. Microbiol. 2015 60 307 314 10.1111/lam.12393 25598393 · DOI
  48. [62]Joseph J.M. Law C. Cross-species examination of single-and multi-strain probiotic treatment effects on neuropsychiatric outcomes Neurosci. Biobehav. Rev. 2019 99 160 197 10.1016/j.neubiorev.2018.11.010 30471308 PMC6601643 · DOI
  49. [63]Chapman C.M.C. Gibson G.R. Rowland I. In vitro evaluation of single-and multi-strain probiotics: Inter-species inhibition between probiotic strains, and inhibition of pathogens Anaerobe 2012 18 405 413 10.1016/j.anaerobe.2012.05.004 22677262 · DOI
  50. [64]Dinan T.G. Stanton C. Cryan J.F. Psychobiotics: A Novel Class of Psychotropic Biol. Psychiatry 2013 74 720 726 10.1016/j.biopsych.2013.05.001 23759244 · DOI · Paper page
  51. [65]Burnet P. Cowen P.J. Psychobiotics highlight the pathways to happiness Biol. Psychiatry 2013 74 708 709 10.1016/j.biopsych.2013.08.002 24144322 · DOI
  52. [68]Nixon A.F. Cunningham S.J. Cohen H.W. Crain E.F. The effect of lactobacillus GG (LGG) on acute diarrheal Illness in the pediatric emergency department (PED) Pediatr. Emerg. Care 2012 28 1048 10.1097/PEC.0b013e31826cad9f 23023475 PMC3760261 · DOI
  53. [70]Sanders M.E. Probiotics and microbiota composition BMC Med. 2016 14 82 10.1186/s12916-016-0629-z 27250499 PMC4890251 · DOI

Authors
Quansah, M., David, M. A., Martins, R., El-Omar, E., Aliberti, S. M., Capunzo, M., Jensen, S. O., & Tayebi, M.
Affiliations
  • University of Ghana (GH)
  • Western Sydney University (AU)
  • Macquarie University (AU)
  • UNSW Sydney (AU)
  • University of Salerno (IT)
  • Ingham Institute (AU)
Corresponding author
Tayebi, Mourad
Venue
Healthcare
Publisher
MDPI AG
Published
2025-01-03
Volume
13
Issue
1
Pages
74
ISSN
2227-9032 (ISSN-L)
OpenAlex
W4406051510
Cited by
21
References
59
Citations by year
2026: 9 · 2025: 12
FWCI
1.72
Type
journal article
Language
en
Open access
Locations
  • Healthcare (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Western Sydney University
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
Lactobacillus, probiotics, Alzheimer's disease, gut microbiota, gut-brain axis, mild cognitive impairment, cognitive function, neurodegenerative diseases, metabolic biomarkers, cognitive decline

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review